Skip to main content

View full-text article in PMC

. 2022 Aug 8;32(12):8266–8275. doi: 10.1007/s00330-022-08945-7

Table 3.

Rates and risk of metastases according to radiological and clinical T-stages

		Lymph node metastases					Bone metastases
	Total	n	%	95% CI	OR	95% CI	n	%	95% CI	OR	95% CI
All patients**
cT1-2	267	19	7	5–11	6.79	3.4–13.2	7	3	1–5	9.91	3.9–25.1
cT3-4	76	26	34	25–45	6.79	3.4–13.2	16	21	13–32	9.91	3.9–25.1
RadT1-2	172	9	5	3–10	4.48	2.1–9.5	0	0	0–2	n.a*	n.a*
RadT3-4	217	43	20	15–26	4.48	2.1–9.5	29	13	9-19	n.a*	n.a*

*Odds ratio cannot be calculated due to no cases of bone metastases in rad T1-2

**Missing cT in 47 patients and missing radT in one patient